Other Species / Isoforms
  4E-BP2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S2
______MSSsAGSGH
0 2
4E-BP2 (human) ______MSSsAGSGH S2
4E-BP2 (mouse) ______MsAsAGGSH S2-p
4E-BP2 (rat) ______MSASAGGGH S2
S4-p
____MSSsAGSGHQP
0 2
4E-BP2 (human) ____MSSsAGSGHQP S4-p
4E-BP2 (mouse) ____MsAsAGGSHQP S4-p
4E-BP2 (rat) ____MSASAGGGHQP S4
R15-m1
GHQPSQSrAIPTRTV
0 1
4E-BP2 (human) GHQPSQSrAIPTRTV R15-m1
4E-BP2 (mouse) SHQPSQSRAIPTRTV R15
4E-BP2 (rat) GHQPSQSRAIPTRTV R15
S25-p
PTRTVAIsDAAQLPH
0 1
4E-BP2 (human) PTRTVAIsDAAQLPH S25-p
4E-BP2 (mouse) PTRTVAISDAAQLPQ S25
4E-BP2 (rat) PTRTVAISDAAQLPQ S25
Y34-p
AAQLPHDyCttPGGt
Upstream
0 60
Treatment
  • Torin1
4E-BP2 (human) AAQLPHDyCttPGGt Y34-p
4E-BP2 (mouse) AAQLPQDyCttPGGt Y34-p
4E-BP2 (rat) AAQLPQDYCTtPGGT Y34
T36-p
QLPHDyCttPGGtLF
0 18
4E-BP2 (human) QLPHDyCttPGGtLF T36-p
4E-BP2 (mouse) QLPQDyCttPGGtLF T36-p
4E-BP2 (rat) QLPQDYCTtPGGTLF T36
T37-p
LPHDyCttPGGtLFs
Upstream
Downstream
2 69
Effects on Modified Protein
  • molecular association, regulation
  • protein conformation
Treatment
  • gefitinib
4E-BP2 (human) LPHDyCttPGGtLFs T37-p
4E-BP2 (mouse) LPQDyCttPGGtLFs T37-p
4E-BP2 (rat) LPQDYCTtPGGTLFs T37-p
T41-p
yCttPGGtLFsttPG
0 11
4E-BP2 (human) yCttPGGtLFsttPG T41-p
4E-BP2 (mouse) yCttPGGtLFsttPG T41-p
4E-BP2 (rat) YCTtPGGTLFsTtPG T41
S44-p
tPGGtLFsttPGGtR
Upstream
0 17
Treatment
  • Torin1
4E-BP2 (human) tPGGtLFsttPGGtR S44-p
4E-BP2 (mouse) tPGGtLFsttPGGtR S44-p
4E-BP2 (rat) tPGGTLFsTtPGGTR S44-p
T45-p
PGGtLFsttPGGtRI
Upstream
0 15
Treatment
  • gefitinib
  • Torin1
4E-BP2 (human) PGGtLFsttPGGtRI T45-p
4E-BP2 (mouse) PGGtLFsttPGGtRI T45-p
4E-BP2 (rat) PGGTLFsTtPGGTRI T45
T46-p
GGtLFsttPGGtRII
Upstream
Downstream
2 94
4E-BP2 (human)
T46-p
4E-BP2 (mouse)
T46-p
Effects on Modified Protein
  • molecular association, regulation
  • protein conformation
Treatment
  • gefitinib
  • Torin1
4E-BP2 (human) GGtLFsttPGGtRII T46-p
4E-BP2 (mouse) GGtLFsttPGGtRII T46-p
4E-BP2 (rat) GGTLFsTtPGGTRII T46-p
T50-p
FsttPGGtRIIyDRK
0 8
4E-BP2 (human) FsttPGGtRIIyDRK T50-p
4E-BP2 (mouse) FsttPGGtRIIYDRK T50-p
4E-BP2 (rat) FsTtPGGTRIIYDRk T50
Y54-p
PGGtRIIyDRKFLLD
0 6
4E-BP2 (human) PGGtRIIyDRKFLLD Y54-p
4E-BP2 (mouse) PGGtRIIYDRKFLLD Y54
4E-BP2 (rat) PGGTRIIYDRkFLLD Y54
K57
tRIIyDRKFLLDRRN
0 1
4E-BP2 (human) tRIIyDRKFLLDRRN K57
4E-BP2 (mouse) tRIIYDRKFLLDRRN K57
4E-BP2 (rat) TRIIYDRkFLLDRRN K57-ac
S65-p
FLLDRRNsPMAQtPP
Upstream
0 22
Treatment
  • ischemia
  • vemurafenib
4E-BP2 (human) FLLDRRNsPMAQtPP S65-p
4E-BP2 (mouse) FLLDRRNsPMAQtPP S65-p
4E-BP2 (rat) FLLDRRNSPMAQTPP S65
T70-p
RNsPMAQtPPCHLPN
Upstream
0 25
Treatment
  • ischemia
  • vemurafenib
4E-BP2 (human) RNsPMAQtPPCHLPN T70-p
4E-BP2 (mouse) RNsPMAQtPPCHLPN T70-p
4E-BP2 (rat) RNSPMAQTPPCHLPN T70
S83-p
PNIPGVTsPGTLIED
0 1
4E-BP2 (human) PNIPGVTsPGTLIED S83-p
4E-BP2 (mouse) PNIPGVTSPGALIED S83
4E-BP2 (rat) PNIPGVTSPGALMED S83